Essex Financial Services’s ImmuCell ICCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $69.6K | Hold |
11,000
| – | – | ﹤0.01% | 786 |
|
|
2025
Q4 | $67.7K | Hold |
11,000
| – | – | ﹤0.01% | 778 |
|
|
2025
Q3 | $68.8K | Hold |
11,000
| – | – | ﹤0.01% | 745 |
|
|
2025
Q2 | $76.6K | Hold |
11,000
| – | – | 0.01% | 685 |
|
|
2025
Q1 | $52.7K | Hold |
11,000
| – | – | ﹤0.01% | 628 |
|
|
2024
Q4 | $56.6K | Hold |
11,000
| – | – | ﹤0.01% | 628 |
|
|
2024
Q3 | $39.7K | Hold |
11,000
| – | – | ﹤0.01% | 624 |
|
|
2024
Q2 | $41.5K | Hold |
11,000
| – | – | ﹤0.01% | 612 |
|
|
2024
Q1 | $58.3K | Hold |
11,000
| – | – | 0.01% | 539 |
|
|
2023
Q4 | $56K | Hold |
11,000
| – | – | 0.01% | 507 |
|
|
2023
Q3 | $58.7K | Sell |
11,000
-3,000
| -21% | -$15.2K | 0.01% | 468 |
|
|
2023
Q2 | $70K | Buy |
14,000
+300
| +2% | +$1.53K | 0.01% | 468 |
|
|
2023
Q1 | $70K | Buy |
13,700
+2,700
| +25% | +$17.5K | 0.01% | 480 |
|
|
2022
Q4 | $67K | Hold |
11,000
| – | – | 0.01% | 471 |
|
|
2022
Q3 | $82K | Hold |
11,000
| – | – | 0.01% | 448 |
|
|
2022
Q2 | $96K | Hold |
11,000
| – | – | 0.01% | 470 |
|
|
2022
Q1 | $106K | Sell |
11,000
-1,718
| -14% | -$14.8K | 0.01% | 497 |
|
|
2021
Q4 | $102K | Sell |
12,718
-1,282
| -9% | -$11.5K | 0.01% | 492 |
|
|
2021
Q3 | $131K | Buy |
+14,000
| New | +$132K | 0.02% | 457 |
|
|
2020
Q4 | – | Sell |
-20,000
| Closed | -$109K | – | 330 |
|
|
2020
Q3 | $109K | Buy |
+20,000
| New | +$111K | 0.03% | 279 |
|
|
2020
Q1 | – | Sell |
-21,600
| Closed | -$111K | – | 260 |
|
|
2019
Q4 | $111K | Hold |
21,600
| – | – | 0.03% | 267 |
|
|
2019
Q3 | $120K | Buy |
21,600
+600
| +3% | +$3.51K | 0.04% | 244 |
|
|
2019
Q2 | $137K | Hold |
21,000
| – | – | 0.04% | 235 |
|
|
2019
Q1 | $133K | Hold |
21,000
| – | – | 0.04% | 228 |
|
|
2018
Q4 | $148K | Sell |
21,000
-2,776
| -12% | -$21.5K | 0.05% | 239 |
|
|
2018
Q3 | $198K | Hold |
23,776
| – | – | 0.04% | 275 |
|
|
2018
Q2 | $162K | Hold |
23,776
| – | – | 0.04% | 263 |
|
|
2018
Q1 | $166K | Hold |
23,776
| – | – | 0.03% | 337 |
|
|
2017
Q4 | $209K | Hold |
23,776
| – | – | 0.05% | 260 |
|
|
2017
Q3 | $155K | Hold |
23,776
| – | – | 0.04% | 270 |
|
|
2017
Q2 | $174K | Hold |
23,776
| – | – | 0.04% | 336 |
|
|
2017
Q1 | $131K | Hold |
23,776
| – | – | 0.03% | 318 |
|
|
2016
Q4 | $141K | Hold |
23,776
| – | – | 0.03% | 316 |
|
|
2016
Q3 | $184K | Hold |
23,776
| – | – | 0.04% | 293 |
|
|
2016
Q2 | $164K | Hold |
23,776
| – | – | 0.04% | 294 |
|
|
2016
Q1 | $163K | Hold |
23,776
| – | – | 0.04% | 299 |
|
|
2015
Q4 | $176K | Hold |
23,776
| – | – | 0.04% | 306 |
|
|
2015
Q3 | $141K | Hold |
23,776
| – | – | 0.04% | 309 |
|
|
2015
Q2 | $187K | Hold |
23,776
| – | – | 0.05% | 312 |
|
|
2015
Q1 | $149K | Hold |
23,776
| – | – | 0.04% | 313 |
|
|
2014
Q4 | $116K | Hold |
23,776
| – | – | 0.03% | 315 |
|
|
2014
Q3 | $118K | Hold |
23,776
| – | – | 0.04% | 293 |
|
|
2014
Q2 | $105K | Hold |
23,776
| – | – | 0.03% | 298 |
|
|
2014
Q1 | $114K | Hold |
23,776
| – | – | 0.04% | 280 |
|
|
2013
Q4 | $101K | Hold |
23,776
| – | – | 0.03% | 273 |
|
|
2013
Q3 | $112 | Hold |
23,776
| – | – | 0.04% | 253 |
|
|
2013
Q2 | $89K | Buy |
+23,776
| New | +$85.2K | 0.03% | 260 |
|
Other funds holding ICCC
VCM
CAM
BL
S
VFT
MFIM
Essex Financial Services's ICCC Position: Q1 2026 in Review
Essex Financial Services held its ImmuCell (ICCC) position steady in Q1 2026 at 11,000 shares worth $69.6K. The position accounts for ﹤0.01% of the portfolio, ranked #786.
Essex Financial Services first reported a position in ICCC in Q2 2013 and has held it in 47 quarters since. The position peaked at $209K in Q4 2017. 27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.
- Essex Financial Services held 11,000 shares of ImmuCell worth $69.6K as of Q1 2026.
- Essex Financial Services left its ImmuCell share count unchanged in Q1 2026.
- ImmuCell made up ﹤0.01% of Essex Financial Services's portfolio in Q1 2026, its #786 holding.
- Essex Financial Services first reported a position in ImmuCell in Q2 2013 and has held it in 47 quarters since.
- Essex Financial Services's ImmuCell position peaked at $209K in Q4 2017.
- 27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.
Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.